Two inhaled Covid-19 vaccines approved in China and India


Two new Covid-19 vaccines that are inhaled, rather than injected, have been approved by China and India respectively. — AFP

Nasal Covid-19 vaccines could help to bring the Covid-19 pandemic under control, the World Health Organization (WHO) said Sept 7 (2022) after such homegrown products were approved in India and China.

The WHO welcomed the new front in the fight against the virus, but also said it wanted to see the data behind the vaccines, to assess whether or not to approve them.

China launched the world’s first inhalable Covid vaccine on Sept 4 (2022), made by CanSino Biologics and administered through a nebuliser.

And India approved a nasally-administered Covid-19 vaccine for emergency use on Sept 6 (2022), developed by Bharat Biotech.

WHO emergencies director Mike Ryan said nasal vaccines generated immune response in the respiratory mucosa in the lungs.

“You’re generating the first line of defence at where the virus enters and causes a lot of damage,” he explained.

In doing so, nasal vaccines could potentially prevent a person from being infected and passing the virus on.

Ryan cited how nasal and injectable vaccines are used in combination to combat diseases such as polio, giving full protection to the internal systems.

That opportunity to reduce both the severity of infection and onward transmission “may offer us a much stronger prospect of control of Covid in the long run”, he told a press conference.

He encouraged innovation that would develop a second and third generation of vaccines “that we may need ultimately to deal with the end of Covid and to deal with future respiratory virus threats”.

WHO’s technical lead on Covid-19 Maria Van Kerkhove welcomed the news.

“We look forward to seeing the data to see how this could be incorporated into the response for Covid-19,” she said.

CanSino and Bharat Biotech both have WHO-approved injectable Covid-19 vaccines.

WHO’s access to vaccines chief Mariangela Simao confirmed that neither manufacturer had yet sought the WHO’s stamp of approval for the new products.

Other manufacturers are also working on nasal vaccines, she added.

WHO chief Tedros Adhanom Ghebreyesus said the continuing global decline in reported Covid-19 cases and deaths was encouraging, but said it was “dangerous” to assume those trends would persist.

“Last week, one person died with Covid-19 every 44 seconds.

“Most of those deaths are avoidable,” he said.

“You might be tired of hearing me say the pandemic is not over. But I will keep saying it until it is.”

Van Kerkhove said it could not yet be predicted whether the SARS-CoV-2 virus behind Covid-19 would settle down into a seasonal pattern like influenza.

The Omicron viral variant’s BA.5 subvariant has become globally dominant, but dozens of subvariants are also still circulating. – AFP Relaxnews

Article type: free
User access status:
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Next In Health

Learn how to breathe properly for exercise and to relax
How to walk faster and burn more calories
Colon cancer is striking at a younger age
The effects of coffee on your heart: What the latest research says
It's not just the liver that's a concern when it comes to too much alcohol
Beware! Smoking masks the signs of gum disease until it gets serious
Looking for a gluten-free, low-carb, versatile food? Cauliflower's your veg
Optimising hearing aids for listening to music
Should we see doctors online or in person?
Drinking coffee could help you to lose weight and lower risk of diabetes: Study

Others Also Read